Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $630 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (NYSE:LLY) and maintained a price target of $630.
November 15, 2023 | 2:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reaffirmed an Overweight rating on Eli Lilly with a steady price target of $630, indicating a positive outlook on the stock.
The reiteration of an Overweight rating by a prominent analyst, along with a high price target, suggests a strong vote of confidence in Eli Lilly's stock performance. This could lead to increased investor confidence and a potential short-term uplift in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100